{"action":"elsewhere","city":"Wilmington","companyRegistrationNumber":null,"conformityFlag":"NON_CONFORMING","country":"US","createdAt":null,"entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[{"category":"DIRECT_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_PUBLIC"],"references":[]},{"category":"ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_PUBLIC"],"references":[]}],"parents":[]},"headquartersAddress":"3344 North Torrey Pines Court, Suite 200, La Jolla","headquartersCity":"San Diego","headquartersCountry":"US","headquartersPostalCode":"92037","headquartersRegion":"US-CA","lastUpdatedAt":"2023-08-04T16:07:24.328Z","legalAddress":"C/O Corporation Service Company, 251 Little Falls Drive","legalFormAbbreviation":null,"legalFormCode":"XTIQ","legalFormName":"Corporation","legalJurisdiction":"US-DE","legalName":"Orexigen Therapeutics, Inc.","lei":"5493008EJF1IXC1DOC52","managingLou":"5493001KJTIIGC8Y1R12","managingLouName":"Bloomberg","managingLouWebsite":"http://lei.bloomberg.com","nextRenewalAt":"2019-02-03T00:31:00.000Z","otherLegalForm":null,"postalCode":"19808","region":"US-DE","registeredAt":"2013-12-05T03:10:00.000Z","registrationAuthorityId":"RA000602","registrationAuthorityName":"Division of Corporations, Department of State","registrationAuthorityWebsite":"https://corp.delaware.gov/","registrationNumber":"3564552","registrationNumberFormatted":"3564552","registrationStatus":"LAPSED","served":false,"successorLeis":[],"validationAuthorityEntityId":"3564552","validationAuthorityId":"RA000602","validationAuthorityName":"Division of Corporations, Department of State","validationSources":"FULLY_CORROBORATED"}